Ing. Jan Verner, Ph.D.
Research specialist, Vladimír Rotrekl Research Group
correspondence Address:
Kamenice 753/5, 625 00 Brno
office: bldg. F01B2/156
Kamenice 126/3
625 00 Brno
phone: | +420 549 49 5437 |
---|---|
e‑mail: | jan.verner@ceitec.muni.cz |
social and academic networks: |
---|
Total number of publications: 61
2021
-
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia
Blood, year: 2021, volume: 138, edition: 9, DOI
-
FoxO1-GAB1 Axis Regulates Homing Capacity and Tonic AKT Activity in Chronic Lymphocytic Leukemia: Novel Therapeutic Target.
Year: 2021, type: Conference abstract
-
GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.
Year: 2021, type: Conference abstract
-
GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target
Year: 2021, type: Conference abstract
-
GAB1 reguluje tonickou AKT signalizaci a migraci buněk chronické lymfatické leukémie: implikace pro kombinační léčbu s BCR inhibitory.
Year: 2021, type: Conference abstract
-
Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro
Journal for ImmunoTherapy of Cancer, year: 2021, volume: 9, edition: 8, DOI
-
In vivo antigen-negative escape to CART-19 caused by CD19 promotor hypermethylation.
Year: 2021, type: Conference abstract
-
Patient-derived Xenograft Model of Chronic Lymphocytic Leukaemia Based on Mimicking Its Microenvironment.
Year: 2021, type: Conference abstract
-
Protein c-Myb: A new prognostic factor in osteosarcoma
Year: 2021, type: Appeared in Conference without Proceedings
-
Transcription factor c-Myb as a functional driver of osteosarcoma progression
Year: 2021, type: Conference abstract